Abbott Laboratories agreed to acquire the remaining stake in privately held Tendyne Holdings Inc. that it doesn't already own for $225 million upfront, resulting in a total transaction value of $250 million, plus potential milestone payments. "Abbott Labs Reaches Deals for Transcatheter Mitral-Valve Developers" published at 11:54 a.m. EDT incorrectly described the terms of the deal in the third paragraph.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.